Riskpilot← Back to searchSign inGet full accessCOLOSSEUM FAUST AS
ASActiveOrg 922950172Lilleengveien 8, 1523 MossMedical specialists activities · NACE 8622Est. 20195 employees
Revenue 2024
NOK 20,4M
-3% vs 2023
EBITDA margin
3.8%
+133% vs 2023
Equity ratio
-299.3%
Financial strength
Net profit 2024
NOK -1,8M
+61% vs 2023
| Revenue | NOK 20,4M | -3% |
| EBITDA | NOK 771K | +133% |
| Net profit | NOK -1,8M | +61% |
| Total assets | NOK 4,7M | -22% |
| Equity | NOK -14M | -6% |
| Employees | 5 | — |
Legal name
COLOSSEUM FAUST AS
Org number
922950172
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
22. juni 2019
Share capital
NOK 540 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Kirurgisk behandling og poliklinisk vurdering av pasienter.
Address
Lilleengveien 8, 1523 Moss
Phone
+4769254000
Email
post@colosseumfaust.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 348 | 17 529 | 22 015 | 21 098 | 20 394 |
| Staff expenses | −1 344 | −1 964 | −3 295 | −3 798 | −3 399 |
| EBITDA | −3 376 | 115 | −571 | −2 335 | 771 |
| Depreciation & amort. | −1 235 | −1 411 | −1 429 | −1 270 | −1 287 |
| EBIT | −4 611 | −1 295 | −2 001 | −3 605 | −516 |
| Net financials | −689 | −702 | −794 | −902 | −1 242 |
| Profit before tax | −5 300 | −1 997 | −2 795 | −4 507 | −1 758 |
| Tax | −1 166 | −439 | 1 896 | −0 | −0 |
| Net profit | −4 134 | −1 558 | −4 691 | −4 507 | −1 758 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 966 | 11 587 | 7 667 | 5 990 | 4 668 |
| Equity | −2 664 | −4 014 | −8 704 | −13 211 | −13 969 |
| Long-term debt | 0 | 10 153 | 10 667 | 10 726 | 9 821 |
| Short-term debt | 13 630 | 5 447 | 5 704 | 8 475 | 8 816 |
| Total debt | 13 630 | 15 600 | 16 371 | 19 201 | 18 637 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20202024
Equity ratio
-299.3%
This company
38.2%
Market median
-884% vs market
20202024
Return on equity
-175781700.0%
This company
18.4%
Market median
-955335426% vs market
20202024
Net profit margin
-8.6%
This company
8.1%
Market median
-206% vs market
20202024
Asset turnover
4.37×
This company
1.12×
Market median
+290% vs market
20202024
Debt / equity
1.33×
This company
0.62×
Market median
-115% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
AF | Board of Directors | 2024 |
| Chairman | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Board of Directors | 2023 – 2024 | |
| Chairman | 2021 – 2023 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2024 | |
| Company | 8% | 8% | 2024 | |
| Company | 8% | 8% | 2024 | |
| Company | 8% | 8% | 2024 | |
| Company | 8% | 8% | 2024 | |
| Company | 8% | 8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ørenesehals Klinikken As
COLOSSEUM FAUST AS Board members of COLOSSEUM FAUST AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Henry Sundøen | Chief Executive Officer | 0 companies |
| Anne Flo | Board of Directors | 0 companies |
| Thomas Haugen Skorpen | Board of Directors | 0 companies |
| Eskild Rudolf Larsen | Chairman | 0 companies |
| Patrik Bø Egeland | Chairman | 0 companies |
| Martin Sture Fagerlund | Chairman | 0 companies |
| Andreas Prøven Bogsrud | Board of Directors | 0 companies |
| Kristian Mydske Vegsgaard | Board of Directors | 0 companies |
| Erik Berg | Board of Directors | 0 companies |
| Gard Lauvsnes | Board of Directors | 0 companies |